Press

  • Rules-Based Medicine, Inc. Launches DiscoveryMAP™ Service for Drug and Diagnostic Development

    Read More >

  • Rules-Based Medicine, Inc. Names Tony Barnes to Lead Expanded Diagnostics Business

    Read More >

  • Rules-Based Medicine, Inc. Launches Human Kidney Damage Biomarker Panel

    • Read More >

  • National Cancer Institute Awards Small Business Innovation Research Contract To Rules-Based Medicine, Inc.

  • All Press

In the News

Multiplex biomarkers on the rise

Michael Spain, M.D., chief medical officer at Rules-Based Medicine, answered questions from R&D Directions about the emergence of multiplex biomarker assays in drug development.

Read More >


Case Study & FAQ

Should I submit mouse serum or plasma to RBM for rodent multi-analyte profiling?

When discussing projects with our customers, they often ask, "Should we collect serum or plasma in our mouse study?"

Read More >